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Abstract.  The targeting signals of two yeast integral 
membrane dipeptidyl aminopeptidases (DPAPs), DPAP 
B and DPAP A, which reside in the vacuole and the 
Golgi apparatus,  respectively, were analyzed.  No sin- 
gle domain of DPAP B  is required  for delivery to the 
vacuolar membrane,  because removal or replacement 
of either the cytoplasmic, transmembrane,  or lumenal 
domain did not affect the protein's transport to the 
vacuole. DPAP A  was localized by indirect immuno- 
fluorescence to non-vacuolar,  punctate structures char- 
acteristic of the yeast Golgi apparatus.  The  118-amino 
acid cytoplasmic domain of DPAP A  is sufficient for 
retention of the protein in these structures,  since re- 
placement of the cytoplasmic domain of DPAP B with 
that of DPAP A  resulted in an immunolocalization pat- 
tern indistinguishable  from that of wild type DPAP A. 
Overproduction of DPAP A  resulted in its  mislocaliza- 
tion to the vacuole, because cells expressing high lev- 
els of DPAP A  exhibited vacuolar as well as Golgi 
staining.  Deletion of 22 residues of the DPAP A  cyto- 
plasmic domain resulted in mislocaiization of the mu- 
tant protein to the vacuole. Thus,  the cytoplasmic do- 
main of DPAP A  is both necessary and sufficient for 
Golgi retention,  and removal of the retention signal, 
or saturation of the retention apparatus by overproduc- 
ing DPAP A, resulted in transport to the vacuole. Like 
wild type DPAP B, the delivery of mutant membrane 
proteins to the vacuole was unaffected in the secretory 
vesicle-blocked secl  mutant;  thus,  transport to the 
vacuole was not via the plasma membrane followed by 
endocytosis. These data are consistent with a  model in 
which membrane proteins are delivered to the vacuole 
along a default pathway. 
M 
Ar~Y proteins  that reside  in  the organelles  of the 
secretory pathway of eukaryotic  cells have target- 
ing information  that directs retention in or sorting 
to the appropriate compartment (Pfeffer and Rothman,  1987). 
In the absence of retention  or sorting  signals,  soluble pro- 
teins of the secretory pathway are secreted; thus, the default 
pathway for these proteins is secretion (Burgess and Kelly, 
1987; Pelham,  1989).  In Saccharomyces  cerevisiae,  muta- 
tions in the targeting  signal of the soluble vacuolar protein, 
carboxypeptidase Y (Vails et al., 1990), or the retention  sig- 
nal of the soluble ER protein, BiP (Hardwick et al.,  1990), 
result in the secretion  of these proteins.  Likewise,  the flow 
of membrane proteins  to the cell surface of nonpolarized 
mammalian cells is apparently by default, because mutations 
that disrupt the retention of ER or Golgi-retained  membrane 
proteins (Machamer et al., 1987; Machamer,  1991; Jackson 
et al., 1990) or the sorting of a lysosomal membrane protein 
(Williams  and Fukuda,  1990)  result  in localization  to the 
plasma membrane.  Little is known regarding membrane pro- 
tein sorting  in S. cerevisiae,  although  a previous study sug- 
gested that the cell surface is the default compartment for 
membrane proteins  (Fuller et al.,  1989b). In this paper, we 
characterize the targeting  of two membrane proteins of the 
yeast secretory pathway, DAP dipeptidyl aminopeptidases 
(DPAPs) ~  DPAP A and DPAP B of the Golgi apparatus  and 
vacuole,  respectively. 
The  biogenesis of two membrane  proteins  of the yeast 
vacuole,  DPAP B (see Fig.  1 A), and alkaline phosphatase 
(ALP), has been characterized  (Klionsky and  Emr,  1989; 
Roberts et al.,  1989).  Both DPAP B and ALP are type II 
membrane  glycoproteins  (nomenclature  of Singer,  1990), 
consisting of NH2-terminal cytoplasmic domains of approx- 
imately  30 amino acids,  single hydrophobic  membrane an- 
chors,  and  COOH-terminal  lumenal  catalytic  domains. 
These proteins transit the early compartments of the secre- 
tory pathway (i.e., ER and Golgi), but not the later compart- 
ments (i.e., secretory vesicles), indicating  that the proteins 
do not transiently  reside at the plasma membrane  before 
delivery to the vacuole. The localization  signals of these two 
proteins have not been identified,  although  the lumenal do- 
main of ALP has been shown to be unnecessary for vacuolar 
targeting  (Klionsky  and Emr,  1990). 
The biosynthesis of several membrane proteins that reside 
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yeast, three membrane-bound proteases, Kex2p, Kexlp, and 
DPAP A (see Fig. 1 A) process the mating pheromone a-fac- 
tor precursor polypeptide as it traverses  the secretory path- 
way  (Bussey,  1988;  Fuller et al.,  1988).  The biosynthetic 
pathways of Kex2p and Kexlp have been characterized (Ful- 
ler et al.,  1989a,b;  Cooper and Bussey,  1989),  and Kex2p 
has  been  shown to  function  in a  late Golgi  compartment 
(Julius et al., 1984; Graham and Emr, 1991). Kex2p has been 
localized  by  indirect  immunofluorescence  to  three  to  six 
punctate structures per cell that exhibit a somewhat random 
distribution within the cytoplasmic compartment (Franzusoff 
et al., 1991; Redding et al., 1991). Thus, the Golgi apparatus 
of yeast is not localized to a perinuclear location, as in mam- 
malian cells, but rather is dispersed throughout the cell. Both 
Kexlp (A. Cooper and H. Bussey, manuscript submitted) and 
DPAP A (see below) have been immunolocalized to punctate 
bodies that are similar to those containing Kex2p  in size, 
abundance,  and distribution. 
In this paper, a combined gene fusion and mutational anal- 
ysis was used to show that no single domain of DPAP B is 
required for vacuolar localization.  Furthermore,  both over- 
production of DPAP A and a mutation in the cytoplasmic do- 
main of DPAP A resulted in mislocalization of this protein 
to the vacuole. Finally,  the fusion proteins analyzed in this 
work are  shown to be transported  directly to the vacuole 
from the Golgi, and not to the plasma membrane. 
Materials and Methods 
Strains, Growth Conditions, and Materials 
The bacterial strain MC1061 (Casadaban and Cohen,  1980) was used for 
all subcloning steps. Oligonucleotide-directed  mutagenesis was carded out 
in strain CJ236 (Kunkel et al., 1987). The yeast strains used were JHRY20- 
1AAIA3 (MATa, dap2A: :  H1S3,  stel3A : :LEU2,  ura3-52, leu2-3, 1eu2412, 
his3-A200,  pep4-3;  Roberts et al.,  1989),  SEY2012zs  (MATch,  dap2:: 
LEU2,  ura3-52,  leu2-3, leu2-112, his4-519, suc2-A 9; Emr et al.,  1983), 
CJRY25-6B (MATa dap2A : :LEU2 mnn9 ura3-52 leu2-3 leu2412, and SEY- 
5016 (  MATa, s e cl-l  , dap  2 : :  LE  U2 , ura3-  5 2 , le  u2-  3, leu2412). Yeast cultures 
were grown in YEPD or minimal (SD) medium supplemented with the ap- 
propriate nutrients as previously described (Sherman et al.,  1982). 
For the simultaneous induction of the GAL/ promoter and the secl4 
secretion defect,  ceils were grown to log phase in minimal media plus 
raltinose and then harvested and resuspended  in YEP-raitinose.  After a 1-h 
incubation at 25~  galactose was added directly to the cultures  and at the 
same time the cultures were shifted to 34~  After 2 h, the cells were fixed 
immediately and prepared for indirect immunofluorescence  as described 
below. 
Oligonucleotides  for mutagenesis were prepared by the University of 
Oregon Biotechnology  Laboratory on an Applied Biosystems 380B DNA 
synthesizer (Foster City, CA) as described (Ito et al., 1982). Tran35S-label 
and Zymolyase 100T were from ICN Biomedicals (Irvine, CA), Endo H 
was from Boehringer Marmheim (Indianapolis,  IN), ultra-pure SDS was 
from BDH Biochemicals (San Francisco, CA), glusulase was from Dupont 
Pharmaceuticals (Wilmington, DE), and all antibodies (except anti-DPAP 
B, anti-DPAP A, anti-ALP, and anti-Vat2p antibodies) used for indirect im- 
munofluorescence were from Jackson ImmunoResearch (West Grove, PA), 
Cappel Products (Malvern, PA), or Promega Biotech (Madison, WI). All 
other reagents were from Sigma Chemical Co. (St. Louis, MO). DPAP and 
invertase assays  were performed as previously described (Gildstein and 
Lampen,  1975; Roberts et al.,  1991). 
Recombinant DNA Methods, Plasmid Constructions, 
and Oligonucleotide-directed  Mutagenesis 
Restriction endonuclease digests and ligations were performed as recom- 
mended by the suppliers.  Plasmid purification,  agarose gel electrophoresis, 
fill-in reactions of sticky-ended DNA fragments using T4 DNA polymerase, 
and DNA-mediated transformation of Escherichia coli were done according 
to standard procedures (Maniatis et al., 1982). Lithium acetate transforma- 
tions of yeast were performed as described (Jto et al.,  1983). 
A disruption of the chromosomal STE/3 locus was constructed by one- 
step gene disruption (l~thstein, 1983), using the plasmid pSLK349 (kindly 
provided by Dr. George Sprague).  pSL349 consists of pBR322 containing 
a 7.2 kbp BamHI STE/3  fragment, from which a  1.6-kbp BclI fragment 
within the coding region of the DPAP A lumenal domain (C. A. Flanagan, 
D. A. Barnes, M. C. Flessel, and J. Thorner, manuscript submitted for pub- 
lication)  was replaced by the 2.9-kbp BglII LEU2  fragment.  To create a 
strain lacking both DPAP A and DPAP B, a disruption of the chromosomal 
DAP2 locus with the HIS3 gene was made using the plasmid pGP6, which 
contains the 1.2-kbp EcoRI-BamHI HIS3 fragment (Sikorski  and Hieter, 
1989) in place of the L3-kbp BstEII-KpnI portion of the coding region of 
DAP2 (Roberts  et al.,  1989). 
The c~-factor signal sequence was fused to the lumenal domain of DPAP 
B as follows: a Sail linker was inserted at the Hincll site of plasmid p771, 
which contains a portion of the 5' region of the MFcd gene (Kurjan and Her- 
skowitz,  1982),  including 70 bp of non-coding region (not including the 
UAS) and 66 bp of coding region, including the signal sequence,  signal pep- 
tidase cleavage site (Waters et al.,  1988),  and 3 NH2-terminal  residues  of 
pro-a-factor, fused to the KRE/gene (Boone et ai.,  1990). The AccI site 
at position  +140  of the DAP2  gene was  changed to a  SalI  site using 
oligonucleotide-directed  mutagenesis (Kunkel et al., 1987). Mutagenesis of 
DAP2 was performed using the vector pCJR27, which contains the 3.3-kbp 
BamHI-HindIII  DA/'2  fragment  in  the  plasmid  KS  +  (Stratagene,  San 
Diego, CA). The 2.7-kbp SalI-HindUI fragment, encoding the lumenal do- 
main of DPAP B, was inserted into the SalI-HindIII sites of p771/SalI, fusing 
the coding regions of MFal and DAP2 in frame, c~Fss-B was placed under 
the control of the GA/_J promoter (Johnston and Davis,  1984) by inserting 
the 2.9-kbp BamHI-HindIII fragment from this plasmid into the BamHI- 
HindIII sites of pC  JR52,  which contains the 822-bp EcoRI-BamHI GA/_,/ 
promoter fragment inserted into EcoRI-BamHI  sites of the CEN plasmid 
pSEYC68 Ca modified version of pSEYC58;  Emr et al.,  1983). The result- 
ing fusion protein consists  of the NH2-terminal  22 residues of prepro-a- 
factor and two residues arising from linker sequences  fused to residue 49 
of the lumenal domain of DPAP B (Fig.  l  B; amino acid sequence  NH2- 
MRFPSIFTAVLFAASSALA-APVGRPHH  .  .  . ). 
The BB-Inv fusion protein expression vectors, pCJR13 and pC JR15 (2p 
and CEN plasmids, respectively),  were constructed by inserting the 0.6-kbp 
BamHI-AccI fragment (AccI blunt ended) into the invertase fusion vectors 
pSEY304  (a derivative of the 2/z plasmid pSEY303;  Emr et al.,  1986) and 
the CEN plasmid pSEYC306 (Johnson et al., 1987) at the BamHI and Hin- 
dIII sites (HindlIJ blunt ended).  The resulting fusion protein contains the 
48 NH2-terminal residues of DPAP B fused to residue three of cytoplasmic 
invertase (Fig. 1 B). BB-Inv was placed under the control of the GAL/pro- 
moter by cutting pCJR15 with EcoRI and HiedIII and ligating in the 822-bp 
GAL/fragment (Johnston and Davis, 1984). This fused the 3' end of the 
GAL/fragment at nucleotide  -92 of the DAP2 sequence.  Vectors encoding 
A20-BB and A27-BB were constructed as follows. Oligonucleotide-directed 
mutagenesis  (Kunkel et al.,  1987) was used to create 60- and 81-bp dele- 
tions in DAP2 (A20-BB and A27-BB, respectively)  in pCJR27.  The ~3.2- 
kbp BamHI-HindIII mutant DAP2 fragments were inserted into the BamHI- 
HindIII sites of the CEN plasmid pSEYC58,  creating  pMNH1  (620-BB) 
and pC  JR45 (A27-BB). &20-BB and A27-BB were over-produced by replac- 
ing the DAP2 promoter with the GAL/promoter as follows. The HindIII 
site at -92 of DAP2 was blunt ended and religated,  creating an NheI site. 
The ~3-kbp NheI-HindIII fragments of pC JR43 and pC  JR44 were inserted 
at the XbaI-HindIII sites of pC  JR52, creating pC  JR56 and pC  JR54, respec- 
tively. The A20 and A27 deletions removed residues 2-21 and 2-27 of DPAP 
B, changing the NH2-terr~nal acid sequence of DPAP B from NH2-MEG- 
GEEEVERIPDELFDTKKKHLLDKLIRV30  to NH2-MHLLDKLIRV  and 
NH2-MIRV, respectively  (Fig.  1 B). 
The 2pt plasmid encoding DPAP A, pCJR46, was constructed as follows: 
the 5.9-kbp  XbaI-BamHI fragment,  containing the STF_J3 gene (C.  A. 
Flanagan, D. A. Barnes, M. C. Flessel, andJ. Thorner, manuscript submitted 
for publication) was isolated  from the plasmid p13-3 (Julius et al.,  1983) 
and inserted into pUC13. The 5.9-kbp SalI-BamI-II fragment from this vec- 
tor was inserted into the XhoI-BglII sites of the 2# plasmid pCKR201 (C. 
Raymond and T. Stevens, unpublished results). The CEN plasmid pCJR78 
was  made by inserting the 4.5-kbp EagI-PvuII STE/3 fragment into the 
EagLEcoRV  sites of pRS316  (Sikorski and Hieter,  1989). 
The plasmid pC  JR64,  encoding the fusion protein AA-B,  was  con- 
structed by inserting the 2.5-kbp BamHI-MluI (MluI blunt ended) fragment 
from p13-3, encoding the STF.J3 promoter and the cytoplasmic  and trans- 
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Figure 1. (A) Comparison of the primary structures of DPAP B and 
DPAP A. The two proteins are diagrammed as rectangles, with the 
NH2 termini at the left, the solid black portions representing the 
transmembrane domains, and the percentages of identical residues 
indicated above. DPAP B and DPAP A are predicted to contain 841 
and 931 amino acids, respectively. The amino acid sequence of the 
cytoplasmic domain of DPAP A is indicated in the one letter amino 
acid code, and the boxed residues are removed by the A22-AAA 
mutation (see below).  (B) Constructs used in the analysis of the 
sorting signal of DPAP B. Each construct is represented as a  rec- 
tangle spanning a lipid bilayer, with the NH2 terminus on the left 
protruding into the cytoplasm. The different domains of each con- 
struct are given a letter depending on their origin (either DPAP A 
or DPAP B). The details of the constructions are given in Materials 
and Methods. The c~Fss-B construct consists of the 22 amino-termi- 
nal  residues  of prepro-a-factor  fused  to  the lumenal domain of 
DPAP B.  The  arrow  indicates the cleavage site by  signal pepti- 
dase. (C) Constructs used in the analysis of the retention signal of 
DPAP A. The hatched regions of A22-AAA and ~22-AAB denote 
the 22-amino acid deletion in the cytoplasmic domains of these 
proteins. 
membrane domains of DPAP A, and the 2.7-kbp Sall-HindlII fragment of 
DAP2 (Sail blunt ended), encoding the lumenal domain of DPAP B, into 
the BamHI-HindlII sites of pSEYC58.  The 5.2-kbp  BamHI-HindlII frag- 
ment of the resulting vector (pCJR41) was cloned into the BamHI-HindlII 
sites of the 2# plasmid, pSEY18 (Emr et al.,  1986). The resulting plasmid 
encodes AA-B, which consists of the NH2-terminal  150 residues of DPAP 
A to residue 47 of DPAP B (Fig.  1 C). 
For the construction of the fusion protein A-BB, XbaI sites were created 
in both the DAP2 and STE/3 genes just upstream of the coding regions of 
the transmembrane domains of DPAP B and DPAP A, respectively,  using 
oligonucleotide-directed  mutagenesis (Kunkel et al., 1987). Nucleotides 69 
and 70 of the DAP2 gene were changed  from GT to TC (Roberts  et al., 
1989), and nucleotides 342-344 of STE/3 were changed from GCC to AGA 
(with the A of the initiation codon as 1) (C. A. Flanagan, D. A. Barnes, 
M. C. Flessel, and J. Thorner, manuscript submitted for publication).  A 1.1- 
kbp SacI-XbaI fragment (encoding the STE13 promoter and the cytoplasmic 
domain of DPAP A) and a 2.8-kbp Xbal-HindlII DAP2 fragment (encoding 
the transmembrane and lumenal domains of DPAP B) were ligated into the 
SacI-HindlII sites of pSEY18. The resulting plasmid (pCJR67)  encodes a 
protein consisting of 113 residues of the NH2-terminal cytoplasmic  domain 
of DPAP A fused to amino acid 24 of DPAP B (Fig.  1 C). 
The  fusion  protein  B-A-B was  constructed  as  follows:  the  3.3-kbp 
BamHI-HindUI DAP2 fragment, including the Xbal site at +70, was ligated 
into the BamHI-HindlII sites of pSEYC58. A 4.3-kbp Xbal-HindlII frag- 
ment of STE/3, encoding the transmembrane and lumenal domains of DPAP 
A,  was  inserted  into  the  XbaI-HindlII sites,  resulting  in  the  plasmid 
pC  JR58. The 2.7-kbp SalI-HindIII DAP2 fragment (SalI blunt ended),  en- 
coding the DPAP B lumenal domain, was inserted into the MluI-HindlII 
sites (MluI blunt ended) of pCJR58, resulting in pCJR69,  a CEN plasmid 
encoding B-A-B. The 4.8-kbp BamHI-HindlII fragment from pCJR69 was 
inserted into the same  sites of pSEY18, resulting in pCJRT0. B-A-B was 
placed under the control of the GAL/promoter by cloning the NheI-HindlII 
B-A-B fragment into the XbaI-HindlII sites of pCJR52,  creating pC  JR79. 
The B-A-B fusion protein consists of residues  116-150 of DPAP A in place 
of residues  26-46 of DPAP B (Fig.  1 C). 
Oligonucleotide-directed  mutagenesis of the portion of STE/3 encoding 
the 118 amino acid cytoplasmic  domain of DPAP A (Fig.  1 A) was per- 
formed in pCJR71,  which consists of the 0.65-kbp  EagI-PstI  fragment of 
STE/3 inserted into the EagI-PstI sites of KS  +. A 66-bp in-frame deletion, 
removing the amino acids  85-106 (z~22), was created,  and the Sacl-MluI 
fragment  from  this  plasmid  was  inserted  into  the  SacI-MluI  sites  of 
pCJR64, creating the 2# plasmid pSN58,  which encodes  A92-AAB (Fig. 
1 C).  The same  SacI-MluI fragment was  ligated  with the 4-kbp MluI- 
Hindlll (encoding the lumenal domain of DPAP A) into the SacI-HindIII 
sites  of pSEY18, creating pSN59,  which encodes A22-AAA (Fig.  1 C). 
A22-AA-B was placed under the control of the GAL/promoter by fusing 
a SacI-EagI fragment from pCJR125  (contains the 360 bp HindlII-EcoRl 
GAL/fragment in pGEM-5Zf) to an Eagl-HindlII fragment from pSN58, 
both of which were ligated into the SacI-HindlII  sites of pSEY18, creating 
pSN89. 
The Fusl-LacZp expression plasmid pCJRll4 as follows: a 6-kb NheI- 
HindllI  fragment,  encoding  the 254  NH2-terminal  amino acids  of the 
FUS1 protein fused to ~-galactosidase,  under the GALl promoter (isolated 
from pCJRll3, a derivative of pSB231  (Trueheart and Fink,  1989)) was 
cloned into the Xbal-Hindlll sites of pVT105U, a 2# plasmid (Vernet et al., 
1987), creating pCJR114. 
For the production of DPAP A antigen to be used to generate DPAP A 
antiserum, the plasmid pCJR24 was constructed by inserting the 0.8-kbp 
MluI-Hpal (MluI blunt ended) STE/3 fragment into the Sinai site of pEXP1, 
an E. coli expression vector containing the Tac promoter just upstream of 
the translational start codon of T4 lysozyme and a multiple cloning site 
(Raymond et al.,  1990). 
Production of  Antiserum against DPAP A and the 
Cytoplasmic Domain of DPAP B 
A 27 amino acid peptide,  corresponding to the 26 NH2-terminal  residues 
of DPAP B followed by a COOH-terminal cysteine residue, was synthesized 
on an Applied Biosystems Peptide Synthesizer. The peptide was coupled to 
carboxymethylated  BSA through the COOH-terminal cysteine with the hi- 
functional crosslinking  agent, MBS,  following the manufacturer's  recom- 
mendations  (Pierce  Chemical  Co.,  Rockford,  IL),  and  through lysine 
residues  with gluteraldehyde  as previously described (Kagen  and Glick, 
1979).  A  1:1  mixture of BSA-peptide conjugates  prepared by the two 
methods was used to immunize rabbits as described previously (Vaitukaitis, 
1981). For affinity purification of the antibody, the poptide was cross-linked 
to Tresyl-activated Sepharose 4B (Pharmacia Fine Chemicals), and affinity 
purification  was carded out as described (Raymond  et al.,  1990). 
DPAP A antigen was produced in E.  coli cells containing the plasmid 
pC  JR24. Induction with IPTG resulted in the production ofa 31-kD protein 
that corresponds to the NHE-terminal  portion of the lumenal domain of 
DPAP A (see Fig.  6) fused to seven residues  of T4 lysosyme  and seven 
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formed as described previously (Raymond et al.,  1990). 
Immunoprecipitations, Endo H Treatment, and High 
pH Carbonate Fractionation 
Immunoprecipitations were performed by growing cultures to log phase in 
supplemented minimal media lacking methionine and cysteine, then pulse 
labeling in the same media with Tran3SS-label and chasing by adding 50 
/~g/mL methionine and 50/~g/mL cysteine, followed by the addition of so- 
dium azide to 10 raM. The cells were converted to spheroplasts (Stevens 
et al., 1986) which were lysed in 1% SDS, 8 M urea plus a protease inhibitor 
cocktail (0.5 mM PMSF,  1/~g/mL leupeptin, and 1 /~g/mL pepstatin) for 
5 rain at 100~  and adjusted to  1 mL in IP buffer (PBS, 0.1%  SDS, 0.1% 
Triton X-100, 1 mivl EDTA). For precipitating ~Fss-B from the extracellular 
fractions, the medium was supplemented with 2 m4,,/mL BSA and 50 mM 
potassium phosphate, pH 5.7. After spberoplasting, the periplasmic and me- 
dia fractions were pooled and adjusted to  1 mL in IP buffer plus protease 
inhibitors.  After pre-adsorbtion to 0.5%  IgGSorb, anti-DPAP B  COOH- 
terminal antibody (Roberts et al.,  1989),  or anti-DPAP A  antibody was 
added,  and samples were incubated one hour on ice.  IgGSorb was added 
to 0.5%, followed by 1 h on ice, and the immune complexes were precipi- 
tated and washed twice with IP buffer. The immune complexes were solubi- 
lized, and half of the samples were treated with endoglycosidase H  (Endo 
H) overnight at 37~  as described (Orlean et al.,  1991).  Samples were ana- 
lyzed by SDS-PAGE and fluorography as described previously (Stevens et 
ai.,  1986). The secretion of t~Fss-B was quantified using an Ambis Radio- 
analytic Imaging System (Ambis Systems,  Inc.,  San Diego,  CA). 
The fractionation of membranes in the presence of high pH sodium car- 
bonate was performed as described (Roberts et al.,  1989). 
Indirect lmmunofluorescence Microscopy 
Preparation of fixed,  spheroplasted cells for indirect immunofluorescence 
was carried out essentially as previously described (Roberts et al.,  1991), 
except that the fixed spheroplasts were treated with 1% SDS for 1-5 minutes. 
Antibody adsorption against fixed spheroplasts harboring null mutations in 
either DAP2 or STEJ3 was performed as described elsewhere (Raymond et 
al.,  1990;  Roberts et ai.,  1991).  The fixed spheroplasts were stained with 
a  1:10 dilution of adsorbed anti-DPAP A  or anti-DPAP B  affinity-purified 
antibody in PBS-BSA (Roberts et al.,  1991).  For co-localization with the 
60-kD subunit of the vacuolar H+-ATPase (Vat2p, the product of the VAT2 
gene; Yamashiro et al.,  1990), the antibody solution also contained a  1:10 
dilution of the mAb,  13Dll (Kane et al.,  1992). The DPAP B or DPAP A 
staining pattern was amplified by subsequent incubations with goat anti- 
rabbit antibody conjugated to biotin, followed by a streptavidin-FITC con- 
jugate.  The last antibody incubation also contained goat anti-rabbit anti- 
body conjugated to rhodamine. Co-detection of ALP and Fusl-LacZp was 
performed by staining cells with a 1:10 dilution of a rabbit polyclonal anti- 
ALP antibody (Raymond et al.,  1990) and a  1:1,000  dilution of a mouse 
monoclonai anti-/~-gaiactusidase antibody, followed by antibody amplifica- 
tion identical to that used for DPAP A and DPAP B. The cells were mounted 
in media containing DAPI for staining nuclei, and photomicrographs were 
made as described previously (Roberts et al.,  1989). 
Results 
The Lumenal Domain of  DPAP B Does Not Contain 
Vacuolar Targeting Information 
The role of the lumenal domain in the sorting of DPAP B to 
the vacuole was addressed in two ways. First, to determine 
if the lumenal domain was sorted to the vacuole when ex- 
pressed in the secretory pathway as a soluble protein, a gene 
fusion was used to create the protein ctFss-B,  consisting of 
the NH2-terminal ER-targeting signal sequence of prepro-t~ 
factor fused to the lumenal domain of DPAP B at residue 49 
(Fig. 1 B). The signal sequence should direct the transloca- 
tion of the protein into the ER lumen and be cleaved, render- 
ing the lumenal domain a soluble protein in the secretory 
Figure 2. Immunoprecipitations of c~FssB from MNN9 and mnn9 
strains. JHRY20-1A (  dap2A MNN9  ) or CJRY25-6B (  dap2A mnn9  ) 
cells were labeled with Tran3sS-label for 15 rain and chased for 
60 min in the presence of  50 izg/mL  methionine and 50/~g/mL cys- 
teine. Cultures were separated into two fractions, intracellular (i.e., 
spheroplasts) and extraceUular (i.e., periplasmic and media), and 
immunoprecipitated with affinity purified DPAP B antibody. Half 
of each immunoprecipitation sample was treated with Endo H, and 
equal amounts were analyzed by SDS-PAGE  and fluorography. Po- 
sitions of the molecular weight standards are indicated (in kD). 
pathway.  The construct was analyzed in a strain which con- 
tains a null allele of DAP2, the structural gene for DPAP B 
(Suarez Rendueles and Wolf, 1987). Fig. 2 shows the results 
of immunoprecipitating o~Fss-B from intraceUular and ex- 
traceUular (i.e., combined periplasmic and medium) frac- 
tions of 35S-labeled cells using an antibody that recognizes 
the COOH-terminal half of DPAP B (Roberts et al.,  1989). 
Analysis  of the  samples by  SDS-PAGE and  fluorography 
showed that 64 % of txFss-B was secreted as a heterogeneous 
population of highly glycosylated species (Fig.  2,  lane 2), 
similar  to  the  secreted  protein  invertase  (Esmon  et  al., 
1981), whereas the intracellular fraction contained a tightly 
migrating  species  (Fig.  2,  lane  /).  Treatment of the  im- 
munoprecipitates with Endo H to remove N-linked carbohy- 
drate demonstrated that the difference in the apparent mobil- 
ities was due to glycosylation (Fig. 2, lanes 3 and 4). The 
glycosylation pattern of the secreted material differs from 
that  of wild  type  DPAP  B,  which  receives  only modest 
glycosyl modifications of the core oligosaccharides in the 
Golgi apparatus (Roberts et al.,  1989). To test whether the 
alteration in glycosylation caused the secretion of the lu- 
menal domain, otFss-B was expressed in an mnn9 mutant, 
which is deficient in the addition of the extensive t~1,6 outer 
chain glycosyl groups (Kukuruzinska et al.,  1987). Fig. 2, 
lanes 5 and 6, show that t~Fss-B was secreted to the same ex- 
tent (59%) from mnn9 cells, even though the protein was not 
aberrantly glycosylated. Indirect immunofluorescence mi- 
croscopy showed that the portion of the lumenal domain that 
remained intracellular was retained in the ER, and no stain- 
ing of  the vacuole was observed (data not shown). Unlike the 
secreted material, the ER-retalned material was enzymati- 
The Journal of Cell Biology, Volume 119,  1992  72 Figure  3.  Immunoprecipita- 
tions of DPAP B, B-A-B, A20- 
BB,  A27-BB, and  BB-Inv. 
JHRY20-1A  (dap2A)  cells 
containing plasmids encoding 
DPAP B (pGP3), B-A-B  (pCJ- 
R70), A20-BB  (pC  JR56), 627- 
BB  (pCJR54), or  SEY2102 
(suc2-A9)  cells  containing 
a  plasmid  encoding  BB-Inv 
(pCJR13) were  labeled  with 
Tran35S-label for 30 rain and 
chased for 60 rain in the pres- 
ence of 50/~g/mL rrw,  thionine 
and  50  /~g/ml cysteine. The 
cells were converted to sphe- 
mplasts,  and extracts  immu- 
noprecipitated  with  either 
affinity-purified DPAP B anti- 
body (lanes 1-8) or affinity-purified  invertase antibody (lanes 9 and 10). Half  of  each immunoprecipitation sample was treated with Endo H, 
and equal amounts were analyzed by SDS-PAGE  and fluorography. Positions of the molecular mass standards for lanes 1-8 are indicated 
(in kD) on the left, whereas standards for lanes 9 and 10 are indicated on the right. 
cally inactive (data not shown), and thus may be unfolded 
and incompetent to exit the ER (Rose et al., 1989; Rothman, 
1989). 
The role of the lumenal domain of  DPAP B in vacuolar tar- 
geting was also tested by constructing the fusion protein BB- 
Inv,  in  which  the  48  NH2-terminal  residues  of DPAP  B 
were fused to the non-vacuolar protein, invertase (Fig. 1 B). 
Immunoprecipitations of BB-Inv using anti-invertase anti- 
body, followed by SDS-PAGE and fluorography, showed that 
the fusion protein was glycosylated, and treatment with Endo 
H showed that the protein was of the expected size (Fig. 3, 
lanes 9 and 10). BB-Inv fractionated with membranes under 
high pH carbonate conditions, consistent with BB-Inv being 
an integral membrane protein (data not shown).  Invertase 
enzyme assays of  either permeabilized or non-permeabilized 
whole cells deleted for the invertase structural gene and ex- 
pressing BB-Inv from a CEN plasmid showed that <2 % of 
the total invertase activity was extracellular. The subcellular 
localization  of  BB-Inv  was  determined  by  indirect  im- 
munofluorescence microscopy using an antibody that recog- 
nizes the cytoplasmic domain of DPAP B (see Materials and 
Methods).  Fig.  4  shows  the staining  pattern of wild type 
DPAP B (Fig. 4, A-C) and BB-Inv (Fig. 4,  G-I) when ex- 
pressed from the high copy number (2#) plasmids,  pGP3 
(Roberts et al.,  1989)  and pCJR13,  respectively. For these 
and the other 2# plasmid constructs used in this study, the 
proteins were overproduced 10-20-fold as determined by en- 
zyme activity.  Both  DPAP  B  and  BB-Inv were localized 
to the vacuolar membrane as judged by differential interfer- 
ence contrast (Nomarski) optics and co-localization with a 
marker for the vacuolar membrane, the 60-kD subunit of the 
vacuolar H+-ATPase  (Vat2p;  Yamashiro et al.,  1990; Table 
I). DPAP B and BB-Inv were also localized to the vacuolar 
membrane when expressed from a single copy (CEN) plas- 
mid (data not shown). Aside from the differences in signal 
intensity, no difference in subcellular localization was ob- 
served when BB-Inv was expressed from CEN or 2# plas- 
mids. The results from the aFss-B and BB-Inv fusions indi- 
cate that,  similar to ALP (Klionsky and Emr,  1990),  the 
lumenal  domain  of  DPAP  B  is  neither  necessary  nor 
sufficient for vacuolar targeting. 
The Cytoplasmic and Transmembrane Domains of 
DPAP B Are Not Necessary  for Vacuolar Targeting 
The role of the transmembrane domain in the vacuolar tar- 
geting of DPAP B was tested by constructing the fusion pro- 
tein B-A-B  (Fig.  1 B),  in which the membrane anchor of 
DPAP B was replaced by that of the non-vacuolar membrane 
protein,  DPAP A.  The role of the cytoplasmic domain of 
DPAP B was tested by constructing in-frame deletions in this 
domain using  oligonucleotide-directed mutagenesis of the 
DAP2  gene.  Two deletion variants of DPAP B  were con- 
structed, A20-BB and A27-BB,  in which 20 and 27 amino 
acids, respectively, were removed from the 29 residue cyto- 
plasmic domain (Fig.  1 B; see Materials and Methods). Im- 
munoprecipitations of B-A-B,  A20-BB,  and  A27-BB from 
35S-labeled cells, followed by SDS-PAGE and fluorography, 
showed that the mutant proteins were glycosylated, and that 
the deglycosylated proteins were of the predicted size (Fig. 
3, lanes 3-8). As with BB-Inv, these proteins behaved as in- 
tegral membrane proteins in high pH carbonate fractionation 
experiments (data not shown). DPAP activity assays of cells 
expressing B-A-B, A20-BB, and A27-BB showed that the pro- 
teins were fully enzymatically active, and that 88-98 % of  the 
total activity was intracellular. 
Indirect immunofluorescence microscopy of ceils express- 
ing B-A-B,  A20-BB, and A27-BB  from either 2# plasmids 
(Fig.  5,  C-H)  or  CEN  plasmids,  using  an  antibody that 
recognizes the COOH-terminal half of DPAP B, showed that 
each of the mutant proteins was predominantly localized to 
the vacuolar membrane as determined by Nomarski optics 
(Fig. 5) and co-localization with Vat2p (data not shown). No 
staining of the plasma membrane was observed for any of 
these proteins.  Thus,  the cytoplasmic and transmembrane 
domains of DPAP B are not necessary for targeting to the 
Roberts et al. Membrane Protein Sorting in Yeast  73 Figure 4. Indirect immunofluorescence  microscopy of  DPAP B and BB-Inv.  JHRY20-1AA  1A3 (dap2zl) cells containing plasmids expressing 
DPAP B (pGP3, A-C), vector alone (pSEYS, D-F), or BB-Inv (pCJR13, G-l) were fixed, converted to spheroplasts, and stained with 
a mouse mAb against Vat2p and affinity purified rabbit antibody specific for either the COOH-terminal half (A-C) or the cytoplasmic 
domain (D-l) of DPAP B as described in Materials and Methods. The cells were viewed by Nomarski optics (A and D) and epifluorescence 
microscopy through filter sets specific for fluorescein (B and E, DPAP B antibody) and rhodamine (C and F,, Vat2p antibody) fluorescence. 
vacuolar membrane. A significant fraction of cells express- 
ing A20-BB and A27-BB also showed some ER localization, 
as judged  by  staining  of the perinuclear  space  and  long 
cisternal compartments (Table I; Rose et al., 1989), whereas 
B-A-B showed only vacuolar labeling. The z~20-BB and ~27- 
BB cells in Fig. 5 show predominantly vacuolar staining. In 
many cases, the plane of focus had to be adjusted to observe 
staining of both vacuolar and ER structures within a given 
cell. The increased residence time of A20-BB and A27-BB 
in  the  ER was  corroborated by immunoblotting analysis, 
which showed that a small amount of the ER forms of A20- 
BB and A27-BB were seen in the steady state, along with the 
Golgi-modified  forms,  whereas  only  the  Golgi-modified 
form was seen for wild type DPAP B (data not shown). The 
increased ER retention of A20-BB and A27-BB could be due 
to an impaired ability to achieve a native conformation com- 
petent for exiting the ER, as has been observed with mutant 
membrane  proteins  in  mammalian  cells  (Gething  et  al., 
1986; Doms et al.,  1988). Upon exiting the ER, however, 
A20-BB and  A27-BB  were transported through the Golgi 
complex to the vacuole, indicating that the cytoplasmic do- 
main of DPAP B is not necessary for vacuolar localization. 
These results,  combined with  those  from the  analysis of 
eeFss-B, BB-Inv, and B-A-B, demonstrate that, aside from a 
membrane anchor, no single domain of DPAP B is required 
for transport to the vacuole. 
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in Wild Type Cells 
Percent of stained cells showing* 
Protein*  Vacuolesw  Golgil)  ER** 
DPAP B  100  2  0 
BB-Inv  1130  ND  0 
B-A-B  100  ND  0 
A20-BB  100  ND  26 
A27-BB  100  ND  87 
DPAP A  5  100  1 
DPAP A, PEP4  1  100  ND 
AA-B  16  100  1 
A-BB  18  100  1 
A22-AAA  100  4  18 
A22-AA-B  100  1  45 
* For each construct, the percentages refer to the fraction of stained cells that 
exhibited staining of a particular organelle. Depending on the protein being 
monitored, some cells showed staining of more than one class of organdie; 
thus, the percentages for a  given protein may add up to more than 100. 
~t JHRY20-IA AtA3 cells (ste13A dap2A pep4-3)  containing 2~ plasmids en- 
coding either DPAP B (pGP3), BB-lnv (pCJR13), B-A-B (pCJRT0),  A20-BB 
(pCJR56),  A27-BB  (pCJR54),  DPAP A  (pCJR46),  AA-B (pCJR64),  A-BB 
(pCJR67),  A22-AAA (pSN59),  or  A92-AA-B (pSN58)  were fixed,  sphero- 
plasted, and stained with either anti-DPAP B lumenal domain antibody (DPAP 
B, B-A-B, A20-BB,  A2,7-BB, AA-B, A-BB, and A22-AA-B), anti-DPAP B 
cytoplasmic  domain antibody  (BB-Inv),  or  DPAP A  antibody  (DPAP  A, 
A22-AAA) and Vat2p mAb for indirect immunofluorescence as described in 
Materials and Methods. DPAP A was also analyzed in an otherwise isogenic 
PEP4 derivative of JHRY20-1A. For all constructs except A22-AAA, >70% 
of the cells in the population showed a signal, and of these >150 cells were 
quantified for each construct. For A22-AAA, ,'~33% of the cells in the popula- 
tion exhibited a  fluorescent signal, and of these 45 were quantified. 
w  Vacuolar localization was determined both by coincidence of staining with 
the vacuole membrane as determined by Nomarski optics, and by co-localiza- 
tion with Vat2p. 
I) Golgi localization was defined as punctate, non-vacuolar, and non-ER stain- 
ing, characteristic of DPAP A,  Kex2p (Redding et al.,  1991),  and Kexlp 
(Cooper and Bussey, manuscript submitted for publication). 
** ER localization was determined by staining of perinuclear (as determined 
by DAPI staining of nuclei) and extended cisternal structures. 
Several  different  models can explain  the data presented 
above (see Discussion), including  a simple model in which 
the vacuolar membrane, not the plasma membrane, is the de- 
fault compartment for membrane proteins of the yeast secre- 
tory pathway. To distinguish  among these models, we ana- 
lyzed the retention signal  of the Golgi membrane protein, 
DPAP A.  Mutations in the retention signal of this protein 
should result in DPAP A becoming localized to the default 
compartment for membrane proteins. 
DPAP  A Is a 112-kD Golgi Membrane Protein 
DPAP A  is a  protein that  resides in the Golgi apparatus, 
where it processes the c~-factor  precursor polypeptide (Julius 
et al.,  1983).  The structural gene for DPAP A (STE23) has 
been cloned and sequenced (Julius et al., 1983; C. A. Flana- 
gun,  D. A. Barnes,  M.  C. Flessel, and J. Thorner,  manu- 
script submitted for publication), and the predicted structure 
of DPAP A is similar to that of DPAP B in several regards. 
Both are type II integral  membrane proteins, and both have 
lumenal enzymatic domains of ,x,800 residues that  share a 
high  degree of sequence identity,  including  48 % identical 
residues over the COOH-terminal 250 residues (Fig.  1 A); 
however, there is no significant sequence similarity  between 
the cytoplasmic and transmembrane domains of DPAP A and 
DPAP B. To assess the subcelhlar distribution  of DPAP A, 
an antibody specific for DPAP  A was generated (see Materials 
and Methods).  The specificity of the antibody is demon- 
st-rated in Fig. 6. Immunoprecipitation of DPAP A was car- 
ried out with 35S-labeled cells that varied with regard to the 
dosage  of the  STE/3  gene.  SDS-PAGE  and  fluorography 
showed that  the antibody immunoprecipitated  a protein of 
112 kD from wild type cells but not from ste13A ceils, and 
that this polypeptide was overproduced ~20-fold in a strain 
containing the STE/3 gene on a 2t~ plasmid (Fig. 6 A). A pro- 
tein of *40 kD was also immunoprecipitated;  however, the 
level of the 40-kD protein did not vary with the dosage of 
STE/3.  The STE/3 DNA sequence predicts  three possible 
sites for addition of N-linked carbohydrate (C. A. Flanagan, 
D.  A.  Barnes,  M.  C.  Flessel, and J.  Thorner,  manuscript 
submitted for publication).  Treatment of DPAP A with Endo 
H  resulted  in  an  ~,5  kD decrease in apparent  molecular 
weight (Fig.  6 B), suggesting  that at least two of the three 
Asn-X-Ser/Thr sites of  DPAP  A were modified, assuming that 
the core oligosaccharides  added were of the typical structure 
(Kukuruzinska  et al., 1987), and that the carbohydrate moi- 
eties were only slightly modified in the Golgi apparatus,  as 
is the case for the glycosyl groups of Kex2p (Fuller et al., 
1989a,b) and Kexlp (Cooper and Bussey, 1989). The appar- 
ent molecular weight of deglycosylated DPAP A, 107 kD, is 
consistent with the molecular weight of DPAP A predicted 
from the STE13 DNA sequence, 107,200 D (C. A. Flanagan, 
D. A. Barnes, M. C. Flessel, andJ. Thorner, manuscript sub- 
mired for publication). 
Indirect immunofluorescence  microscopy of cells contain- 
ing the $7F,/3 gene on a 2# plasmid showed that DPAP A was 
localized to several non-vacuolar puncture patches dispersed 
throughout  the cell, as judged by Nomarski optics and  in 
double staining  experiments  with Vat2p antibody (Fig.  7, 
D-U).  This signal  was absent in a steI3A strain  (Fig.  7, 
A-C). This staining pattern is typical of the Golgi apparatus, 
as determined by the localization  of Kex2p (Redding et al., 
1991) and Kexlp (A, Cooper and H. Bussey, manuscript sub- 
mitted for publication).  Attempts to localize DPAP A in cells 
containing only the chromosomal copy of STE/3 were unsuc- 
cessful due to the low abundance of the protein.  Because the 
copy number of yeast 2/~ plasmids can vary from 10-40 cop- 
ies/cell  within a population (Rose and Broach,  1991), the 
fluorescence  signal  corresponding  to  DPAP A  when  ex- 
pressed from a 2# plasmid also varied from cell to cell, rang- 
ing from a weak signal to a very strong signal,  whereas the 
intensity of the Vat2p signal was consistent from cell to cell. 
All of the cells that showed a signal with the DPAP A anti- 
body displayed a Golgi-staining  pattern (Fig. 7, D-U; Table 
I); however, cells exhibiting a very strong signal, presumably 
due to a high dosage of the STE/3 gene, also showed vacuolar 
staining (5 % of the cells ofapep4-3 strain;  Table I). An ex- 
ample of this is shown in Fig. 7, (~ S, and U). A single cell 
exhibiting a strong DPAP A signal is shown, and the signal 
stains both vacuolar and punctate non-vacuolar structures,  as 
judged by co-localization  with Vat2p. The percentage of cells 
showing vacuolar localization  of DPAP A decreased signifi- 
cantly in an otherwise isogenic PEP4 strain,  which contains 
the full complement of vacuolar proteases (I %;  Table I). 
Thus,  cells producing high levels of DPAP A showed mis- 
localization  of the protein to the vacuolar membrane, with 
the mislocalized  protein degraded in a vacuolar protease- 
dependent fashion. 
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cence microscopy of B-A-B, A20- 
BB,  and  A27-BB.  JHRY20-1A 
AIA3 (dap2A) ceils harboring the 
vector with no insert  (pSEYS, A 
and  B),  or  plasmids  expressing 
B-A-B (pCJR70, C and D),  A20- 
BB (pCJR56, E and F), or A27-BB 
(pCJR54,  G  and  H)  were  fixed, 
converted  to  spheroplasts,  and 
stained with DPAP B antibody as 
described  in Materials  and Meth- 
ods. The ceils were viewed by No- 
marski optics (A, C, E, and G) and 
by epifluorescence using a filter set 
specific for fluorescein fluorescence 
(B, D, F, and H). 
DPAP enzyme assays on permeabilized and non-perme- 
abilized cells expressing DPAP A  from either CEN or 2g 
plasmids showed that ,088% of the total activity was intra- 
cellular; thus, it is possible that a small percentage of DPAP 
A is present at the cell surface, even though no plasma mem- 
brane staining was detected by indirect immunofluorescence, 
However, the apparent extraceUular DPAP A enzyme activity 
could in part be due to a  small degree of cell lysis during 
the assay. 
The Cytoplasmic Domain of  DPAP  A Is SuJ~icient  for 
Retention in the Golgt Apparatus 
To determine whether a  specific domain of DPAP A  con- 
The Journal of Cell Biology, Volume 119, 1992  76 Figure 6. (.4)  Immunoprecipitations of DPAP A. JHRY20-1A strains of genotype stel3A (A), STEI3 (+), or S/'EJ3 harboring the 2/z-STE/3 
plasmid pCJR46 (2/,) were labeled with TranasS-label for 60 rain, chased with cold methionine and cysteine for 30 rain, and DPAP A 
was immunoprecipitated. The samples were analyzed by SDS-PAGE  and fluorography. Half as much material was loaded in the 2# lane:. 
The positions of  the molecular mass standards are indicated (in kD). (B) Endo H treatment. DPAP A, AA-B, and A-BB  were immunoprecip- 
itated from Tran3SS-labeled  cells, half of the samples were treated with Endo H, and equal amounts of treated and untreated samples were 
analyzed by SDS-PAGE and fluorography. 
tained the signal  for Golgi retention,  the fusion proteins 
AA-B and A-BB were constructed (Fig.  1 C), in which the 
lumenal domain of  DPAP A was exchanged for that of  DPAP 
B (AA-B), and the cytoplasmic domain of DPAP B was ex- 
changed for that of DPAP A  (A-BB). Immunoprecipitation 
of AA-B  and  A-BB  from  35S-labeled  cells,  followed  by 
SDS-PAGE and fluorography, showed that both fusion pro- 
teins were glycosylated and treatment of the immunoprecipi- 
tates with Endo H showed that the proteins were of the ex- 
pected  size  (Fig.  6  B).  The  broadly  migrating  species 
observed for AA-B and A-BB indicate that the proteins are 
more extensively modified in the Golgi apparatus than DPAP 
A. DPAP activity assays on permeabilized or non-permeabi- 
lized whole cells demonstrated that the AA-B and A-BB pro- 
teins were enzymatically active, and that ~80% of the activ- 
ity was intracellular. A-BB fractionated with membranes in 
the presence of high pH sodium carbonate, and thus behaves 
biochemically as  an integral membrane protein  (data  not 
shown). 
Indirect immunofluorescence  microscopy using anti-DPAP 
B lumenal domain antibody showed that AA-B and A-BB ex- 
hibited  non-vacuolar  punctate  staining  patterns  indistin- 
guishable from wild type DPAP A (Fig. 8, A-F). Again, no 
plasma membrane staining was detected. As with DPAP A, 
all cells that showed a  signal displayed a punctate staining 
pattern, and a subset of those cells that showed a strong sig- 
nal  also exhibited vacuolar localization (Table I).  An ex- 
ample is shown in Fig. 8 (A-C) for cells expressing AA-B. 
The cell in the bottom right corner shows a very intense flu- 
orescein signal relative to the other cells in the panel, and 
clearly exhibits co-localization with  Vat2p.  Thus,  as  was 
seen for wild type DPAP A, overproduction of these proteins 
resulted in some mislocalization to the vacuole. These ex- 
periments demonstrate that the cytoplasmic domain of  DPAP 
A  is  sufficient for the retention of an otherwise vacuolar 
membrane protein in punctate structures typical of the Golgi 
apparatus in S. cerevisiae. The cytoplasmic domain of  DPAP 
A also has been shown to be sufficient for Golgi retention 
when fused to the transmembrane and lumenal domains of 
the vacuolar membrane protein ALP (S.  Nothwehr and 1". 
Stevens, unpublished data). 
A Mutation in the DPAPA Cytoplasmic Domain 
Results in Its Delivery to the Vacuole 
To determine if the cytoplasmic domain of DPAP A was also 
necessary for the retention of DPAP A in the Golgi, a series 
of in-frame deletion mutations in the cytoplasmic domain 
were generated using oligonucleotide-directed mutagenesis 
(see Materials and Methods). Deletion variants that lacked 
Roberts et al. Membrane Protein Sorting in Yeast  77 Figure 7. Immunolocalization of DPAP A. JHRY'20-1A (ste13A) cells containing either a 2/~ plasmid containing the STE/3 gene (pCJR46; 
D-U) or no insert (pSEYS; A-C) were fixed, spheroplasted, and stained with DPAP A antibody and Vat2p mAb. The cells were viewed 
by Nomarski optics (A, D, G, J, K, P, and Q) and by epifluorescence using filter sets specific for fluorescein (B, E, H, L, M, R, and S) 
and rhodamine (C, F, 1, N, O, T, and U) fluorescence. 
residues 2-84 or 108-116 of the 118 amino acid cytoplasmic 
domain exhibited punctate localization patterns  similar to 
wild type DPAP A (S. Nothwehr, C. Roberts, and T. Stevens, 
unpublished data). However, deletion of the 22-residue seg- 
ment 85-106 from either DPAP A or the fusion protein AA-B 
(A22-AAA and A22-AA-B; see Fig.  1 C) resulted in mis- 
localization of the proteins to the vacuole (Fig. 9), although 
both proteins also showed a small amount of ER staining (Ta- 
ble I). Immunoblotting analysis of crude extracts prepared 
from cells expressing A22-AA-B showed a broadly migrating 
species on SDS-PAGE similar to AA-B and A-BB (data not 
shown;  Fig.  6  B),  suggesting that the  A22-AA-B protein 
transits the Golgi apparatus before its transport to the vacu- 
ole. Similar to the deletions in the cytoplasmic domain of 
The Journal  of  Cell  Biology,  Volume 119,  1992  78 Figure 8. Immunolocalization of AA-B and A-BB. JHRY'20-1A (ste13A dap2A) cells containing plasmids expressing either AA-B (pCJR64, 
A-C) or A-BB (pCJR67, D-F) were fixed, spheroplasted, and stained with DPAP A antibody and Vat2p mAb. The cells were viewed 
by Nomarski optics (A and C) and by epifluorescence using filter sets specific for fluorescein (B and E) and rhodamine (C and F) fluores- 
cence. 
DPAP B, this deletion delays exit of the fusion proteins from 
the ER; however, upon exit from the ER, the enzymatically 
active A22-AAA and A22-AA-B fusion proteins were trans- 
ported to the vacuole. Thus, the cytoplasmic domain is both 
necessary and sufficient for the retention of DPAP A in the 
Golgi apparatus, and the signal for the retention of DPAP A 
maps to a 22-amino acid segment within the ll8-residue cy- 
toplasmic domain. 
Transport to the Vacuole Does Not Involve prior 
Delivery to the Plasma Membrane 
We have previously shown that the transport of DPAP B to 
the vacuole does not involve delivery to the plasma mem- 
brane followed by endocytic targeting to the vacuole (Rob- 
errs  et  al.,  1989).  This  was  demonstrated  by  expressing 
DPAP B in a secl mutant, which at 34~  is blocked at a late 
stage of the secretory pathway and accumulates secretory 
vesicles (Novick et al., 1981; Salminen et al., 1987). To ad- 
dress the possibility that the mutant constructs analyzed in 
this study were mislocalized to the plasma membrane fol- 
lowed by rapid endocytic uptake to the vacuole, indirect im- 
munofluorescence experiments were performed on BB-Inv, 
B-A-B, A20-BB, and/x22-AA-B expressed in a secl strain at 
34~  As a positive control for accumulation in secretory 
vesicles, the localization of the fusion protein Fusl-LacZp 
was analyzed (Trueheart et al., 1987). The FUS1 gene prod- 
uct is required for the breakdown of the cell walls after the 
fusion of a  and ct cells during conjugation (McCaffrey et 
al.,  1987;  Trueheart et  al.,  1987),  and  has  been  shown 
by protease treatment of whole yeast cells to be a plasma 
membrane protein (Trueheart and Fink,  1989). The fusion 
protein  Fusl-LacZp,  consisting  of the  254  NH2-terminal 
amino acids of  Fuslp fused to the/acZ gene product (/3-galac- 
tosidase), has been shown by immunofluorescence micros- 
copy to be localized to the plasma membrane after induction 
during mating (Trueheart et al.,  1987). 
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AAA and A22-AA-B.  JHRY20-1A  (stel3A 
dap2A)  cells  containing  plasmids  ex- 
pressing either A22-AAA (pSN59, A-F) 
or A22-AAB (pSN58,  G--L) were fixed, 
spheroplasted,  and stained with DPAP B 
(A-F) or DPAP A (G-L) antibody,  and 
Vat2p mAb.  The cells  were viewed  by 
Nomarski optics (A, D, G, and J) and by 
epifluorescence  using filter sets specific 
for fluorescein  (B, E, DPAP A antibody; 
H, K, DPAP B antibody) and rhodamine 
(C, F, I, and L; Vat2p antibody) fluores- 
cence. 
For these  experiments,  the  expression  of these  proteins 
was under the control of the inducible GAL/promoter (see 
Materials and Methods; Johnston and Davis, 1984). Neither 
Fusl-LacZp, BB-Inv, B-A-B, or A20-BB showed any signal be- 
fore addition of galactose (data not shown).  Fig.  10 (A-F) 
shows that Fusl-LacZp was localized to the plasma mem- 
brane in a  SEC  § strain after 2  h  of induction at 34~  but 
accumulated  intracellularly,  presumably  in  secretory vesi- 
cles,  in  a  secl  strain  under  the  same  conditions.  No co- 
localization with the vacuolar marker,  ALP,  was detected. 
Figure 10. Immunolocalization in SEC* and 
secl  strains.  JHRY20-1A (SEC*) and SEY- 
5016 (secl) cells  containing plasmids  en- 
coding  Fusl-LacZp  (pCJRll4)  or  B-A-B 
(pCJR79)  under  the  control of the  GAL/ 
promoter were grown to log phase in media 
containing raffinose, then shifted to 34~  at 
the same time that galactose was added to 
the cultures.  After 2 h, the cells were fixed, 
spheroplasted,  and prepared  for immuno- 
fluorescence.  Cells expressing  Fusl-LacZp 
were  stained  with  anti-/~-galactosidase 
mAb  and  anti-ALP  polyclonal  antibody, 
and were viewed using  filter  sets  specific 
for  fluorescein  and  rhodamine  fluores- 
cence, respectively. Cells expressing B-A-B 
were stained  as in Fig.  5. 
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after Induction in secl cells 
Intracellular,  Plasma 
Protein~  Vacuolesw  non-vacuolart  membrane 
Fus-LacZp, SEC §  0  0  100 
Fusl-LacZp, secl  0  97  3 
BB-Inv, secl  100  0  0 
B-A-B, secl  77  23  0 
A20-BB,  secl  98  2  0 
* For each construct,  the percentages refer to the fraction of stained cells that 
exhibited  staining  of  a  particular  organelle.  SEY5016  cells  (secl-1)  or 
JHRY20-1A  cells  (SEC§  containing  plasmids  encoding  either  Fusl-LacZp 
(pCJR114),  BB-Inv (pCJR51),  B-A-B (pCJR79),  or A20-BB (pCJR56) were 
grown to log phase, then shifted to 34~  at the same time that galactose was 
added to the culture, and incubated for 2 h. The cells were then fixed, sphero- 
plasted,  and stained with either  LacZp antibody (Fusl-LacZp),  NHz-terminal 
DPAP B antibody (BB-lnv), or COOH-terminal DPAP B antibody (B-A-B and 
A20-BB)  for indirect  immunofluorescence  as described  in Methods.  For all 
constructs,  >70%  of the cells in the population showed a signal, and of those 
at least  100 cells  were quantified for each construct. 
Vacuolar localization was determined both by coincidence of staining with 
the vacuole membrane as determined by Nomarski optics and by co-localiza- 
tion with either ALP (Fusl-lacZ)  or Vat2p (BB-lnv, B-A-B, and A20-BB). 
Typically, Fusl-LacZp accumulated in a large patch in the 
bud and bud neck region of budded cells, and near the cell 
periphery of unbudded cells. BB-Inv,  B-A-B, and A20-BB 
were each localized to the vacuole under these conditions 
(e.g., Fig.  10, G-l; Table II), as defined by co-localization 
with Vat2p. The intraceUular,  non-vacuolar signal occasion- 
ally observed for B-A-B (23 %; Table II) was different from 
that of Fusl-LacZp, in that the signal looked reminiscent of 
the Golgi signal observed for DPAP A (data not shown). This 
was also observed for B-A-B in SEC  § cells at 34~  sug- 
gesting that the kinetics of delivery of this protein is slowed 
at elevated temperatures. The analysis of A22-AA-B in the 
secl strain was complicated by the fact that expression of the 
protein  was  leaky;  ,~50%  of the  cells  in  the population 
showed a weak vacuolar staining pattern before galactose ad- 
dition. However,  addition of galactose to the culture after 
shifting the cells to 34~  resulted in '~90% of the cells ex- 
hibiting an intense vacuolar signal (data not shown). These 
data show that the BB-Inv, B-A-B, A20-BB,  and A22-AA-B 
proteins are targeted directly from the Golgi apparatus to the 
vacuole without transient appearance  at the cell  surface; 
thus, these proteins follow the same route to the vacuole as 
wild  type  vacuolar  membrane  proteins  (Roberts  et  al., 
1989). 
Discussion 
The  search  for  the  vacuolar  localization determinant  of 
DPAP B led to the surprising conclusion that neither the cy- 
toplasmic, transmembrane, nor lumenal domain of the pro- 
tein was  necessary for vacuolar delivery. Analysis of the 
Golgi retention signal of DPAP A led to the equally surpris- 
ing observations that both overproduction of the protein and 
mutations in the cytoplasmic domain resulted in mislocaliza- 
tion of DPAP A to the vacuole, not the plasma membrane. 
These results were unexpected, given that the targeting of 
soluble vacuolar proteins in yeast and soluble and membrane 
proteins of  the lysosomes of  animal cells require targeting in- 
formation to prevent delivery to the cell surface (Vails et al., 
1990; Kornfeld and Mellman, 1989; Williams and Fukuda, 
1990;  Machamer,  1991). 
The fusion proteins analyzed in this study are appropriate 
tools for these experiments for the following reasons. All of 
the proteins were stable, enzymatically active, membrane- 
bound, and glycosylated  when expressed in yeast, indicating 
that they have the correct membrane topology. In addition, 
all of  the fusion proteins containing the DPAP B lumenal do- 
main, i.e., A20-BB,  A27-BB, B-A-B, and A22-AA-B,  were 
transported to the vacuole after receiving glycosyl modifica- 
tions in the Golgi apparatus.  Finally, each of these fusion 
proteins was  transported to the vacuole directly from the 
Golgi apparatus, without prior delivery to the plasma mem- 
brane followed by endocytic uptake to the vacuole. 
Other Golgi membrane proteins have also been shown to 
be mislocalized to the vacuole rather than the plasma mem- 
brane. Both mutations in the cytoplasmic domain of Kexlp 
as well as its overproduction result in mislocalization of the 
protein to the vacuolar membrane (A. Cooper and H. Bus- 
sey, manuscript submitted for publication). Similarly, a sin- 
gle amino acid change in the cytoplasmic domain of Kex2p 
results in its transport to the vacuole (C. Wilcox, K. Red- 
ding, R.  Wright, and R.  Fuller, manuscript submitted for 
publication).  Whereas this result might appear to conflict 
with earlier published data on Kex2p, more recent analysis 
indicates that membrane-bound forms of Kex2p that fail to 
be retained in the Golgi are found in the vacuole rather than 
the plasma membrane, when these proteins are expressed at 
wild type or modestly elevated levels (C. Wilcox, K. Red- 
ding, R.  Wright, and R.  Fuller, manuscript submitted for 
publication). 
Given that several Golgi membrane proteins all show mis- 
sorting to the vacuole when either mutant or overproduced, 
the model we favor to explain these data is the vacuolar de- 
fault model, which states that vacuolar membrane proteins 
do not require sorting information, because the default path- 
way for membrane proteins of the secretory pathway leads 
to the vacuole. Alternatively, one could argue that, given the 
similarity between DPAP  B  and DPAP A,  both proteins 
could contain vacuolar targeting information in their trans- 
membrane domains, even though no significant similarity is 
apparent from the amino acid sequence data (C. A. Flana- 
gan, 13. A. Barnes, M. C. Flessel, and J.  Thorner, manu- 
script  submitted for publication).  Mutations in the Golgi 
retention signal of DPAP A, or saturation of  the retention ap- 
paratus, would then result in the delivery of DPAP A to the 
vacuole. This model requires that both Kex2p and Kexlp 
must also have cryptic vacuolar targeting signals. With re- 
gard to the cryptic vacuolar targeting signal model, we have 
found that replacement of the membrane spanning domains 
of DPAP A and A22-AAA with a 21 residue hydrophobic se- 
quence,  L(LALV)~,  creating the proteins AXA and A22- 
AXA, results in the retention of AXA in the Golgi and the 
transport of A22-AXA to the vacuole (S. Nothwehr and T. 
Stevens,  unpublished  data).  These  data  suggest  that  the 
transmembrane domain of DPAP A  does not contain vac- 
uolar targeting information, and thus support the vacuolar de- 
fault model. The vacuolar default model is directly testable 
by analyzing potential localization signals of yeast plasma 
membrane proteins. 
In apparent conflict with the vacuolar default model is the 
observation that the majority of Kex2p (70%) is missorted 
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chain (Payne and Schekman,  1989).  However,  DPAP A is 
missorted to the cell surface to a lesser extent (30 %; Seeger 
and Payne, 1992a).  It is possible that the majority of DPAP 
A and a significant percentage of Kex2p are missorted to the 
vacuole in cells lacking clathrin heavy chain. Mutations in 
clathrin may affect both the retention of Golgi membrane 
proteins and the functional integrity of the sorting pathway 
(Seeger and Payne, 1992b).  This could obscure the default 
pathway for membrane proteins, resulting in the transport of 
Golgi membrane proteins to the plasma membrane as well 
as the vacuole. 
An alternative explanation of the data is that one or more 
of the DPAP A and DPAP B fusion or mutant proteins ana- 
lyzed in this study were in a partially unfolded state, and thus 
recognized as abnormal and transported directly from the 
ER to the vacuole via a "garbage" pathway. There is no clear 
evidence for the existence of such a pathway in yeast or ani- 
mal cells. However, several cases have been described in ani- 
mal cells in which non-lysosomal membrane proteins were 
transported to lysosomes, either due to mutations (Arm- 
strong et al.,  1990),  or in the case of the heptameric T-cell 
antigen  receptor,  complexes  lacking  the  ~"  subunit  are 
degraded in lysosomes (Minami et al., 1987). In these cases, 
the proteins were transported through the Golgi apparatus, 
and it is unclear whether the proteins were transported to 
lysosomes by a "garbage" pathway, or by the uncovering of 
a cryptic lysosomal targeting signal. In the great majority of 
cases,  mislocalized  membrane  proteins  of the  secretory 
pathway in animal cells accumulate at the plasma membrane, 
which is presumed to be the default destination for these pro- 
teins (e.g., Williams and Fukuda,  1990).  It is well estab- 
lished that proteins that are slow to reach the folded state are 
retained in the ER due to the action of proteins such as BiP 
(Pelham,  1989;  Rothman, 1989),  and proteins that are un- 
able to fold or oligomerize properly are degraded in the ER 
(Klausner and Sitia, 1990).  Several of the proteins analyzed 
in this study (i.e., A20-BB,  A27-BB, A22-AAA, and A22- 
AA-B) showed increased retention in the ER. However, all 
of these proteins eventually exited the ER, were enzymati- 
cally active, and were transported through the Golgi com- 
plex to the vacuole. 
The 22-amino acid segment of the cytoplasmic domain of 
DPAP A presumably contains the recognition domain for a 
"retention protein" of  the Golgi apparatus. This protein could 
be a permanent resident of  the Golgi apparatus; alternatively, 
the "retention protein" could reside in a post-Golgi compart- 
ment and function as a salvage receptor, such as the proposed 
receptor for soluble ER proteins (Pelham,  1989).  It is in- 
teresting to note that the 22-amino acid stretch identified as 
the DPAP A Golgi retention signal contains five phenylala- 
nine residues (Fig. 1). In animal cells, one or more aromatic 
amino  acids  in  the  cytoplasmic  domains of cell  surface 
receptors have been shown to comprise part of the signal for 
the clustering into coated pit regions of the plasma mem- 
brane (Chen et al., 1990; Johnson et al., 1990; Lobel et al., 
1989; McGraw et al., 1991). That the phenylalanine  residues 
in the A22 region may play a direct role in Golgi retention 
is supported by the observation that mutations in just two of 
these residues result in a  substantial level of missorting of 
DPAP A to the vacuole (S. Nothwehr and T. Stevens, unpub- 
lished data). 
The results of this study suggest that the default pathway 
for membrane proteins of the yeast secretory pathway may 
be different from that of certain mammalian cell lines that 
have been examined, where mutant forms of ER, Golgi, and 
lysosomal membrane proteins are mislocalized to the plasma 
membrane with the bulk flow of membrane (Machamer and 
Rose,  1987; Jackson et al.,  1990;  Williams and Fukuda, 
1990;  Wieland  et  al.,  1987; Karrenbauer  et  al.,  1990; 
Machamer, 1991). However,  in polarized epithelial ceils, it 
remains unclear which membrane serves as the default desti- 
nation for membrane proteins (Simons and Wandinger-Ness, 
1990;  Mostov et al.,  1992).  Even if the default compart- 
ments for membrane proteins of the secretory pathways of 
yeast  and  certain  animal  cells  are  different,  the  same 
mechanistic considerations apply, that is, positive sorting in- 
formation is required for proteins to avoid delivery to the de- 
fault compartment. 
According to the vacuolar default model for yeast mem- 
brane protein sorting, not only must ER and Golgi mem- 
brane proteins have sorting signals specifying their retention 
in the appropriate compartment, but plasma membrane pro- 
teins are predicted to have sorting information that prevents 
their localization to the vacuole. We are currently investigat- 
ing whether yeast plasma membrane proteins have targeting 
signals that prevent their transport to the vacuole. 
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